Sequent Scientific has informed as they have been approached by certain media houses seeking clarification on the news of observation issued by USFDA on the Company’s plant at Mangalore. In this connection, they wish to confirm that Sequent's facility at Mangalore was inspected by USFDA between Jun 29, 2015 and July 03, 2015 as part of their regular CGMP audit. There was one observation (483s) relating to employee training management processes. The said observation has been attended to and a suitable response has been provided to the USFDA within the stipulated timeline.
The above information is a part of company’s filings submitted to BSE.
